Bayerische Motoren Werke Aktiengesellschaft (OTCMKTS:BMWYY) vs. SWEDISH ORPHAN/S (OTCMKTS:SWTUY) Head to Head Comparison

SWEDISH ORPHAN/S (OTCMKTS:SWTUY) and Bayerische Motoren Werke Aktiengesellschaft (OTCMKTS:BMWYY) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

Insider and Institutional Ownership

0.0% of Bayerische Motoren Werke Aktiengesellschaft shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Valuation and Earnings

This table compares SWEDISH ORPHAN/S and Bayerische Motoren Werke Aktiengesellschaft”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SWEDISH ORPHAN/S	$763.19 million	8.71	$134.73 million	$0.50	48.76
Bayerische Motoren Werke Aktiengesellschaft	$168.28 billion	0.31	$12.22 billion	$6.06	4.82

Bayerische Motoren Werke Aktiengesellschaft has higher revenue and earnings than SWEDISH ORPHAN/S. Bayerische Motoren Werke Aktiengesellschaft is trading at a lower price-to-earnings ratio than SWEDISH ORPHAN/S, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

SWEDISH ORPHAN/S has a beta of 1.81, indicating that its share price is 81% more volatile than the S&P 500. Comparatively, Bayerische Motoren Werke Aktiengesellschaft has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for SWEDISH ORPHAN/S and Bayerische Motoren Werke Aktiengesellschaft, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SWEDISH ORPHAN/S	0	0	0	0	0.00
Bayerische Motoren Werke Aktiengesellschaft	1	1	0	0	1.50

Profitability

This table compares SWEDISH ORPHAN/S and Bayerische Motoren Werke Aktiengesellschaft’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SWEDISH ORPHAN/S	25.75%	29.63%	18.74%
Bayerische Motoren Werke Aktiengesellschaft	6.90%	11.39%	4.19%

Summary

SWEDISH ORPHAN/S beats Bayerische Motoren Werke Aktiengesellschaft on 6 of the 11 factors compared between the two stocks.

About SWEDISH ORPHAN/S

Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B. It also provides Orfadin for the treatment of hereditary tyrosinaemia type 1; and Kineret for the treatment of auto inflammatory condition, as well as Xiapex to treat Dupuytren's contracture and Peyronie's disease. In addition, the company manufactures drug substance for ReFacto AF; and develops BIVV001 and BIVV002 for the treatment of hemophilia. It operates in Sweden, the Middle East, North Africa, Russia, North America, other European countries, and internationally. The company has an agreement with Bioverativ for the development and commercialization of Elocta and Alprolix, as well as XTEN-programs. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden.

About Bayerische Motoren Werke Aktiengesellschaft

Bayerische Motoren Werke Aktiengesellschaft, together with its subsidiaries, engages in the development, manufacture, and sale of automobiles and motorcycles, and spare parts and accessories worldwide. It operates through Automotive, Motorcycles, and Financial Services segments. The Automotive segment engages in the development, manufacture, assembling, and sale of automobiles, spare parts, accessories, and mobility services under the BMW, MINI, and Rolls-Royce brands. The Motorcycles segment develops, manufactures, assembles, and sells motorcycles and scooters under the BMW Motorrad brand, as well as spare parts and accessories. The Financial Services segment is involved in the automobile and motorcycle leasing, credit financing, retail and dealership financing, multi-brand fleet, customer deposit, and insurance activities; and the provision of fleet management services under the Alphabet brand. The company sells its products through independent dealerships. Bayerische Motoren Werke Aktiengesellschaft was founded in 1916 and is headquartered in Munich, Germany.